Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-26 @ 10:17 PM
Study NCT ID:
NCT00343512
Status:
TERMINATED
Last Update Posted:
2012-04-27
First Post:
2006-06-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2008-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-22
First Submit QC Date:
None
Study First Post Date:
2006-06-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-10-11
Results First Submit QC Date:
None
Results First Post Date:
2010-11-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-04-21
Last Update Post Date:
2012-04-27
Last Update Post Date Type:
ESTIMATED